newsfilter
← Latest News
GlobeNewswire·

Inhibikase Therapeutics Announces Planned Retirement of Chief Financial Officer Joseph Frattaroli

BOSTON and ATLANTA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to